CD274 and non-small cell lung carcinoma: PD-L1 is the predominant ligand for PD-1 and is highly expressed on many solid and haematological tumours including ovarian [28], breast [29], cervical [30], melanoma [31], colon [32], glioblastoma [33] and NSCLC [34] as well as DCs and macrophages [35].